Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency - Summary of Warrants Activity (Details)

v3.5.0.2
Stockholders' Deficiency - Summary of Warrants Activity (Details)
 3 Months Ended
Mar. 31, 2016
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of Shares Warrants outstanding | shares 61,043,591
Number of Shares Warrants granted | shares 2,142,857
Number of Shares Warrants exercised | shares
Number of Shares Warrants canceled/forfeited/expired | shares (5,305,235)
Number of Shares Warrants outstanding | shares 57,881,213
Number of Shares Warrants exercisable | shares 57,881,213
Weighted Average Exercise Price Warrants outstanding at Beginning Balance | $ / shares $ 1.08
Weighted Average Exercise Price Warrants granted | $ / shares 1.00
Weighted Average Exercise Price Warrants exercised | $ / shares
Weighted Average Exercise Price Warrants canceled/forfeited/expired | $ / shares 2.35
Weighted Average Exercise Price Warrants outstanding at Ending Balance | $ / shares 0.96
Weighted Average Exercise Price Warrants exercisable | $ / shares $ 0.96
Weighted Average Remaining Life In Years Outstanding 2 years 7 months 6 days
Weighted Average Remaining Life In Years Exercisable 2 years 7 months 6 days
Aggregate Intrinsic Value Outstanding | $ $ 126
Aggregate Intrinsic Value Exercisable | $ $ 126